Loading...
Back to narrative

EVLV: ARR Momentum Will Set Up A Breakout Year In 2026

Update shared on 22 Jan 2026

02 Jun
US$5.25
AnalystLowTarget's Fair Value
US$10.00
47.5% undervalued intrinsic discount
Loading
1Y
-37.9%
7D
-4.0%

Narrative Update on Evolv Technologies Holdings

Analysts have raised their price target on Evolv Technologies Holdings to $10 from $9, citing a recent quarterly performance described as a strong beat and noting expectations that by 2026 annual recurring revenue growth could exceed reported revenue growth.

Analyst Commentary

The latest price target change to US$10 highlights that some on the Street see upside potential, but even supportive research comes with clear caveats around how the story could play out over the next few years. The excitement around a recent quarterly beat and discussion of 2026 as a possible breakout year sit alongside questions about how much of that optimism is already reflected in expectations.

Bearish analysts are paying close attention to whether future annual recurring revenue growth can sustainably outpace reported revenue growth, especially as the company scales. For you as an investor, the key debate is not just where the share price could go, but how consistently the company can execute against the growth implied by these targets.

Bearish Takeaways

  • Bearish analysts question whether the current valuation already prices in a strong 2026 outlook, which could leave limited room for disappointment if growth or customer adoption trends are slower than expected.
  • There is concern that recent quarterly strength may be hard to repeat consistently, raising execution risk around bookings, renewals and the timing of larger deals that feed into annual recurring revenue.
  • Some see a risk that recurring revenue growth might not consistently exceed reported revenue growth, which could pressure sentiment if investors are focused on that specific longer term narrative.
  • Bearish analysts also highlight that higher expectations embedded in a raised price target can increase volatility around future earnings reports, especially if guidance or reported metrics fall short of investor benchmarks.

What's in the News

  • Evolv Express is being deployed at Pechanga Arena San Diego, a 14,000 seat sports and entertainment venue, expanding the company’s presence across major Southern California arenas and stadiums, including Crypto.com Arena, SoFi Stadium and several others (Client announcement).
  • The company raised its 2025 total revenue guidance to a range of US$142 million to US$145 million, compared with prior guidance of US$132 million to US$135 million, and linked this to a focus on operational efficiency, profitability and cash flow (Corporate guidance).
  • Evolv reported that its AI based bag screening solution, Evolv eXpedite, has screened over 1,000,000 bags since launch, while Evolv Express has screened over 3 billion people worldwide across venues such as theme parks, stadiums, schools and hospitals (Product announcement).
  • Spartanburg District Five Schools in South Carolina expanded its deployment to 29 Evolv Express systems and four eXpedite units across all 14 schools, citing goals around both safety and efficient entry during peak times and events (Client announcement).

Valuation Changes

  • Fair Value: The fair value estimate remains unchanged at 9.5, indicating no adjustment to the central valuation point in this update.
  • Discount Rate: The discount rate has risen slightly from 8.48% to 8.51%, which can modestly reduce the present value of future cash flows in the model.
  • Revenue Growth: The revenue growth assumption has risen slightly from 16.77% to 17.39%, implying a marginally higher growth profile in the updated inputs.
  • Net Profit Margin: The net profit margin assumption has fallen slightly from 8.75% to 8.19%, pointing to a more cautious view on future profitability levels.
  • Future P/E: The future P/E multiple has risen slightly from 135.17x to 142.30x, reflecting a higher valuation multiple applied to expected earnings in the updated scenario.

Have other thoughts on Evolv Technologies Holdings?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Comments

0 comments

Disclaimer

AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.